A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.

Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT00206284
Collaborator
(none)
1,400
202
11
6.9
0.6

Study Details

Study Description

Brief Summary

The primary objective is to compare the efficacy between three doses of AZD0865 (25, 50 and 75 mg). The secondary objectives are to compare the efficacy between the three doses of AZD0865 and esomeprazole 20 mg and to evaluate the safety and tolerability of AZD0865.

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A 4-week, Randomised, Double-blind, Multicentre, Dose-finding Phase IIb Study With AZD0865 25, 50, 75 mg and Esomeprazole 20 mg, Given Orally Once Daily for the Treatment of GERD Without Erosive Esophagitis According to the LA Classification in Adult Subjects.
Study Start Date :
May 1, 2004
Actual Study Completion Date :
Apr 1, 2005

Outcome Measures

Primary Outcome Measures

  1. Time to sustained absence of patient-reported heartburn. []

Secondary Outcome Measures

  1. The Quality of Life in Reflux and Dyspepsia (QOLRAD). []

  2. Patient-reported symptoms. []

  3. Investigator-reported symptoms. []

  4. Population pharmacokinetics (PK). Area under the concentration-time curve (AUC) and the oral clearance calculated by dose/AUC (CL/F). []

  5. pH monitoring. []

  6. Histology. []

  7. Safety (Adverse events, Laboratory variables, BP, pulse, ECG and physical examination). []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Identification of their main symptom as heartburn defined as a burning feeling behind the breastbone.

  • Have at least a 6-month history of heartburn and at least 4 days of episodes of heartburn with at least overall moderate intensity during the last 7 days prior to visit 1.

  • Have an absence of mucosal breaks in the esophagus, as defined by the LA classification, at the visit 1 endoscopy.

  • Have provided Informed consent.

Exclusion Criteria:

Subjects with current or historical evidence of the following conditions are excluded from the study:

  • Erosive esophagitis.

  • Esophageal columnar metaplasia (Barrett's esophagus) of 1.0 cm or greater.

  • Esophageal stricture.

  • Primary esophageal motility disorder(s), i.e. diffuse esophageal spasm, achalasia.

  • Systemic Sclerosis (scleroderma).

  • Irritable Bowel Syndrome (IBS), i.e. upper abdominal discomfort or pain that in the opinion of the Investigator is likely to be due to IBS or fulfilling two or more of the criteria: relieved by defecation, associated with change in frequency of stools, associated with change in form (appearance) of stools.

  • Inflammatory bowel disease.

  • Zollinger-Ellison syndrome.

  • Gastric ulcer, duodenal ulcer or duodenal erosions within the last 3 months

Subjects with i) history of significant or ii) current significant or unstable:
  • Cardiovascular diseases or cardiac chest pain.

  • Cerebrovascular diseases, such as cerebral ischemia, infarction, haemorrhage, or embolus.

  • Diabetes mellitus. Stable diabetes controlled on diet, oral agents or insulin is acceptable.

  • Pulmonary, renal, pancreatic or liver diseases or any other serious disease as judged by the investigator to interfere with the evaluation of the current study.

  • Malignant disease (except for minor superficial skin disease).

  • Generalised bleeding disorders.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Research Site Alabaster Alabama United States
2 Research Site Huntsville Alabama United States
3 Research Site Tucson Arizona United States
4 Research Site North Little Rock Arkansas United States
5 Research Site Anaheim California United States
6 Research Site Cypress California United States
7 Research Site Garden Grove California United States
8 Research Site Lancaster California United States
9 Research Site Los Angeles California United States
10 Research Site Mission Hills California United States
11 Research Site Orange California United States
12 Research Site Rancho Cucamonga California United States
13 Research Site San Diego California United States
14 Research Site Torrance California United States
15 Research Site Wheat Ridge Colorado United States
16 Research Site Manchester Connecticut United States
17 Research Site Davie Florida United States
18 Research Site Gainesville Florida United States
19 Research Site Hialeah Florida United States
20 Research Site Jacksonville Florida United States
21 Research Site Jupiter Florida United States
22 Research Site Miami Florida United States
23 Research Site Ocoee Florida United States
24 Research Site W Palm Beach Florida United States
25 Research Site Zephyr Hills Florida United States
26 Research Site Atlanta Georgia United States
27 Research Site Austell Georgia United States
28 Research Site Conyers Georgia United States
29 Research Site Chicago Illinois United States
30 Research Site Moline Illinois United States
31 Research Site Rockford Illinois United States
32 Research Site Clive Iowa United States
33 Research Site Overland Park Kansas United States
34 Research Site Metairie Louisiana United States
35 Research Site Shreveport Louisiana United States
36 Research Site Annapolis Maryland United States
37 Research Site Baltimore Maryland United States
38 Research Site Hollywood Maryland United States
39 Research Site Laurel Maryland United States
40 Research Site Towson Maryland United States
41 Research Site Picayune Mississippi United States
42 Research Site Jefferson City Missouri United States
43 Research Site Kansas City Missouri United States
44 Research Site Butte Montana United States
45 Research Site Willingboro New Jersey United States
46 Research Site Charlotte North Carolina United States
47 Research Site Elkin North Carolina United States
48 Research Site Fayetteville North Carolina United States
49 Research Site Greensboro North Carolina United States
50 Research Site Greenville North Carolina United States
51 Research Site High Point North Carolina United States
52 Research Site Raleigh North Carolina United States
53 Research Site Canton Ohio United States
54 Research Site Guthrie Oklahoma United States
55 Research Site Oklahoma City Oklahoma United States
56 Research Site Duncansville Pennsylvania United States
57 Research Site Pittsburgh Pennsylvania United States
58 Research Site Anderson South Carolina United States
59 Research Site Georgetown South Carolina United States
60 Research Site Mt Pleasant South Carolina United States
61 Research Site Simpsonville South Carolina United States
62 Research Site Bristol Tennessee United States
63 Research Site Chattanooga Tennessee United States
64 Research Site Jackson Tennessee United States
65 Research Site Knoxville Tennessee United States
66 Research Site Nashville Tennessee United States
67 Research Site Austin Texas United States
68 Research Site Dallas Texas United States
69 Research Site Houston Texas United States
70 Research Site Ogden Utah United States
71 Research Site Salt Lake City Utah United States
72 Research Site Christiansburg Virginia United States
73 Research Site Norfolk Virginia United States
74 Research Site Richmond Virginia United States
75 Research Site Spokane Washington United States
76 Research Site Tacoma Washington United States
77 Research Site Milwaukee Wisconsin United States
78 Research Site Abbotsford British Columbia Canada
79 Research Site Vancouver British Columbia Canada
80 Research Site Halifax Nova Scotia Canada
81 Research Site Guelph Ontario Canada
82 Research Site Hamilton Ontario Canada
83 Research Site Mississauga Ontario Canada
84 Research Site North York Ontario Canada
85 Research Site Ottawa Ontario Canada
86 Research Site Thornhill Ontario Canada
87 Research Site Toronto Ontario Canada
88 Research Site Levis Quebec Canada
89 Research Site Longueuil Quebec Canada
90 Research Site Montreal Quebec Canada
91 Research Site Saskatoon Saskatchewan Canada
92 Research Site Quebec Canada
93 Research Site St. John's Canada
94 Research Site Aalborg Denmark
95 Research Site Birkerød Denmark
96 Research Site Esbjerg Denmark
97 Research Site Herning Denmark
98 Research Site Holbæk Denmark
99 Research Site Hvidovre Denmark
100 Research Site Kolding Denmark
101 Research Site København K Denmark
102 Research Site København NV Denmark
103 Research Site Odense Denmark
104 Research Site Randers Denmark
105 Research Site Vejle Denmark
106 Research Site Viborg Denmark
107 Research Site Århus C Denmark
108 Research Site Espoo Finland
109 Research Site Helsinki Finland
110 Research Site Lahti Finland
111 Research Site Mikkeli Finland
112 Research Site Pori Finland
113 Research Site Tampere Finland
114 Research Site Turku Finland
115 Research Site Vantaa Finland
116 Research Site Ales France
117 Research Site Angers France
118 Research Site Beausoleil France
119 Research Site Bordeaux France
120 Research Site Caen France
121 Research Site Cannes La Bocca France
122 Research Site Choisy Le Roi France
123 Research Site Dreux France
124 Research Site Hazebrouck France
125 Research Site Issoire France
126 Research Site Marseille France
127 Research Site Narbonne France
128 Research Site Paris France
129 Research Site Saint Quentin France
130 Research Site Talence France
131 Research Site Vitry Sur Seine France
132 Research Site Berlin Germany
133 Research Site Celle Germany
134 Research Site Dresden Germany
135 Research Site Görlitz Germany
136 Research Site Köln Germany
137 Research Site Leipzig Germany
138 Research Site Ludwigshafen Germany
139 Research Site Magdeburg Germany
140 Research Site Mainz Germany
141 Research Site München Germany
142 Research Site Oelde Germany
143 Research Site Potsdam Germany
144 Research Site Ribnitz-Damgarten Germany
145 Research Site Wolmirstedt Germany
146 Research Site Bologna Italy
147 Research Site Brescia Italy
148 Research Site Genova Italy
149 Research Site Mestre Italy
150 Research Site Milano Italy
151 Research Site Napoli Italy
152 Research Site Palermo Italy
153 Research Site Parma Italy
154 Research Site Pisa Italy
155 Research Site Roma Italy
156 Research Site Bergen Norway
157 Research Site Bodø Norway
158 Research Site Drammen Norway
159 Research Site Gjøvik Norway
160 Research Site Levanger Norway
161 Research Site Nesttun Norway
162 Research Site Oslo Norway
163 Research Site Stavanger Norway
164 Research Site Tromsø Norway
165 Research Site Trondheim Norway
166 Research Site Karlskrona Sweden
167 Research Site Kristianstad Sweden
168 Research Site Kungälv Sweden
169 Research Site Malmö Sweden
170 Research Site Mora Sweden
171 Research Site Nyköping Sweden
172 Research Site Skövde Sweden
173 Research Site Stockholm Sweden
174 Research Site Sundsvall Sweden
175 Research Site Säffle Sweden
176 Research Site Täby Sweden
177 Research Site Varberg Sweden
178 Research Site Värnamo Sweden
179 Research Site Östersund Sweden
180 Research Site Ashford United Kingdom
181 Research Site Atherstone United Kingdom
182 Research Site Cambridge United Kingdom
183 Research Site Cheltenham United Kingdom
184 Research Site Coventry United Kingdom
185 Research Site Derby United Kingdom
186 Research Site Dundee United Kingdom
187 Research Site Dunfermline United Kingdom
188 Research Site Epsom United Kingdom
189 Research Site Glasgow United Kingdom
190 Research Site Hamilton United Kingdom
191 Research Site Kent United Kingdom
192 Research Site Lancaster United Kingdom
193 Research Site Manchester United Kingdom
194 Research Site Slough United Kingdom
195 Research Site Somerset United Kingdom
196 Research Site Stafford United Kingdom
197 Research Site Stockport United Kingdom
198 Research Site Telford United Kingdom
199 Research Site Torquay United Kingdom
200 Research Site West Bromwich United Kingdom
201 Research Site West Yorks United Kingdom
202 Research Site Woking United Kingdom

Sponsors and Collaborators

  • AstraZeneca

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00206284
Other Study ID Numbers:
  • D9770C00011
First Posted:
Sep 21, 2005
Last Update Posted:
Jan 4, 2013
Last Verified:
Jan 1, 2013
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 4, 2013